1z3n: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /> <applet load="1z3n" size="450" color="white" frame="true" align="right" spinBox="true" caption="1z3n, resolution 1.04Å" /> '''Human aldose reduct... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1z3n.gif|left|200px]]<br /> | [[Image:1z3n.gif|left|200px]]<br /><applet load="1z3n" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="1z3n" size=" | |||
caption="1z3n, resolution 1.04Å" /> | caption="1z3n, resolution 1.04Å" /> | ||
'''Human aldose reductase in complex with NADP+ and the inhibitor lidorestat at 1.04 angstrom'''<br /> | '''Human aldose reductase in complex with NADP+ and the inhibitor lidorestat at 1.04 angstrom'''<br /> | ||
==Overview== | ==Overview== | ||
Recent efforts to identify treatments for chronic diabetic complications | Recent efforts to identify treatments for chronic diabetic complications have resulted in the discovery of a novel series of highly potent and selective 3-[(benzothiazol-2-yl)methyl]indole-N-alkanoic acid aldose reductase inhibitors. The lead candidate, 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat, 9) inhibits aldose reductase with an IC(50) of 5 nM, while being 5400 times less active against aldehyde reductase, a related enzyme involved in the detoxification of reactive aldehydes. It lowers nerve and lens sorbitol levels with ED(50)'s of 1.9 and 4.5 mg/kg/d po, respectively, in the 5-day STZ-induced diabetic rat model. In a 3-month diabetic intervention model (1 month of diabetes followed by 2 months of drug treatment at 5 mg/kg/d po), it normalizes polyols and reduces the motor nerve conduction velocity deficit by 59% relative to diabetic controls. It has a favorable pharmacokinetic profile (F, 82%; t(1/2), 5.6 h; Vd, 0.694 L/kg) with good drug penetration in target tissues (C(max) in sciatic nerve and eye are 2.36 and 1.45 mug equiv/g, respectively, when dosed with [(14)C]lidorestat at 10 mg/kg po). | ||
==About this Structure== | ==About this Structure== | ||
1Z3N is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with NDP and 3NA as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Aldehyde_reductase Aldehyde reductase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.1.1.21 1.1.1.21] Full crystallographic information is available from [http:// | 1Z3N is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=NDP:'>NDP</scene> and <scene name='pdbligand=3NA:'>3NA</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Aldehyde_reductase Aldehyde reductase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.1.1.21 1.1.1.21] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1Z3N OCA]. | ||
==Reference== | ==Reference== | ||
| Line 15: | Line 14: | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Dicioccio, A | [[Category: Dicioccio, A T.]] | ||
[[Category: Geraci, L | [[Category: Geraci, L S.]] | ||
[[Category: Gunn, D | [[Category: Gunn, D E.]] | ||
[[Category: Jacot, J | [[Category: Jacot, J L.]] | ||
[[Category: Jones, J | [[Category: Jones, J H.]] | ||
[[Category: Jones, M | [[Category: Jones, M L.]] | ||
[[Category: Mitschler, A.]] | [[Category: Mitschler, A.]] | ||
[[Category: Petrova, T.]] | [[Category: Petrova, T.]] | ||
[[Category: Podjarny, A | [[Category: Podjarny, A D.]] | ||
[[Category: Sawicki, D | [[Category: Sawicki, D R.]] | ||
[[Category: Sredy, J.]] | [[Category: Sredy, J.]] | ||
[[Category: Zandt, M | [[Category: Zandt, M C.Van.]] | ||
[[Category: 3NA]] | [[Category: 3NA]] | ||
[[Category: NDP]] | [[Category: NDP]] | ||
| Line 33: | Line 32: | ||
[[Category: oxidoreductase]] | [[Category: oxidoreductase]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:11:52 2008'' | ||